(BTS) Difficult Asthma Network)., London, UK; 4 Queen's University Belfast (on behalf of the British Thoracic Society (BTS) Difficult Asthma Network)., Belfast, UK 10.1136/thoraxjnl-2013-204457.322 Introduction and Objectives NICE Guidance for bronchial ther- moplasty (BT) recommended the collection of safety and efficacy outcomes through the BTS Difficult Asthma Registry. This study summarises the data collected to June 2013, with objectives of describing the demographic and baseline characteristics of patients undergoing BT and early consideration of safety and efficacy, which will be updated for presentation at the December 2013 meeting. Methods Records for 21 patients from 5 UK centres were studied. Age, gender, lung function and quality of life were com- pared to those reported in two previous clinical trials. Potential safety issues were examined and efficacy outcomes compared to baseline. Results Data:20 baseline records, 62 BT procedure records, 9 patients followed up to 6 months, 7 followed up to 12 months. At follow-up, 12 patients had data at 6 and/or 12 months for pre bronchodilator FEV 1 and AQLQ to enable comparison with baseline. Baseline demographics and characteristics are presented in Table 1. Outcomes: one patient was re-admitted to hospital for 3 days with an exacerbation after the second of three routine BT proce- dures, but recovered to complete the final procedure. 17 patients were admitted post-procedure (max 8 days) but no adverse out- comes were reported. Mean AQLQ score at 6 months was 4.61 ± 1.80 (n = 10). 6/10 patients had improved AQLQ (> 0.5 above baseline) at 6 months and 2/3 at 12 months. 1/10 patients had worse AQLQ (> than 0.5 below baseline) at 6 months and 0/3 at 12 months. Mean pre-bronchodilator FEV 1 (% of predicted) at 6 months was 64.88 ± 26.57 (n = 8) and at 12 months 75.20 ± 13.77 (n = 5). Conclusions Early indications are that this cohort are marginally older and have worse mean lung function and AQLQ scores at baseline than patients in two previous clinical trials.No serious issues relating to equipment or adverse outcomes were observed. Patients were often admitted post-procedure - this may have been precautionary, as there were no reports of unanticipated procedural morbidity. To date, efficacy outcomes appear consis- tent with those observed in previous clinical trials, with a sugges- tion of smaller improvement in AQLQ score. Abstract P171 Table 1. Baseline demographics and characteristics. BT registry AIR2 trial AIR trial Mean age (years) 44.3 ± 11.5 (n=21) Range 23-69 40.7 ± 11.9 (BT) 40.6 ± 11.9 (C) 40.0 ± 11.2 (BT) 40.8 ± 12.1 (C) % female 57 59 57 Pre-bronchodilator FEV 1 (% of predicted) 70.25 ± 23.5 (n=16) range: 22-105 77.8 ± 15.7 (BT) 79.7 ± 15.1 (C) 72.5 ± 10.9 (BT) 74.9 ± 8.9 (C) AQLQ score 4.17 ± 1.2 (n=14) range 2.44 - 6.31 4.30 ± 1.17 (BT) 4.32 ± 1.21 (C) 5.6 ± 0.9 (BT) 5.6 ± 0.9 (C) Monitoring and management of sleep disordered breathing and respiratory failure P172 ACUTE NIV AND MORTALITY - FAILURE OF DELIVERY OR PATIENT SELECTION? S Zaidi, K MacFarlane, K Dodd, V Ford, K Ward, H Ashcroft, J Cheney, V Molyneux, B Chakrabarti, J O'Reilly, N Duffy, R Angus, R Parker; Aintree University Hospital NHS Foundation Trust, Liverpool, United Kingdom 10.1136/thoraxjnl-2013-204457.323 Background Non-invasive ventilation (NIV) is an established treatment for patients with acute ventilatory failure. It can be successfully provided on a specialist ward, rather than intensive care (ICU) when certain criteria are met. It is frequently deliv- ered outside ICU when a patient is deemed not suitable for inva- sive ventilation. Methods Deaths in 2012 on our dedicated ventilation unit were analysed as part of ongoing clinical governance. Information on demographics, admission diagnosis, respiratory and metabolic acidosis, consolidation or pulmonary oedema on chest radio- graph reports, Glasgow Coma Score (GCS), serum creatinine and hospital length of stay prior to NIV were recorded. Escala- tion of care and resuscitation decisions were noted. Results There were 228 admissions for acute NIV, with 31 recorded deaths (13.6%), 22 case notes were available for review. Mean age was 79 years, 77.3% had known COPD, admission median MRC score of 4, and 18.2% had been in hos- pital for >7 days before NIV. All had acute hypercapnic respira- tory failure. Not for resuscitation decisions had been made for 95.5% prior to NIV, and 100% had NIV as a ‘ceiling of care’. Mean pH was 7.25 (SD 0.06), similar to previous reports of admissions to our unit 1 , 22% had mixed acidosis (BE <-2.0 mmol/l). GCS was <8 in 9% and 36.4% had serum creatinine >100 mmol/l, all triggering alerts for acute kidney injury. Admis- sion diagnoses are shown in figure 1. Radiographic consolidation was reported in 59.1% and pulmonary oedema in 18.2%. Abstract P172 Figure 1. Admitting diagnoses based on initial clinician assessment. Conclusion The mortality of patients receiving acute NIV is low 2 . Most deaths had an underlying diagnosis of COPD, they were an elderly frail group, deemed inappropriate for escalation to critical care. There were multiple risk factors for NIV failure on initiation of therapy. Whilst a trial of NIV may have been appropriate based purely on blood gases, it was at high risk of failure and discussion about end of life care may have offered an alternative approach. REFERENCES 1. Chakrabarti et al. Thorax 2009;857–62. 2. Roberts et al. Thorax 2010;43–8. Poster sessions Thorax 2013;68(Suppl 3):A1–A220 A153 on May 30, 2020 by guest. Protected by copyright. http://thorax.bmj.com/ Thorax: first published as 10.1136/thoraxjnl-2013-204457.323 on 14 November 2013. Downloaded from
Poster sessions
S Zaidi, K MacFarlane, K Dodd, V Ford, K Ward, H Ashcroft, J Cheney, V Molyneux,
B Chakrabarti, J O'Reilly, N Duffy, R Angus, R Parker; Aintree University Hospital NHS
Foundation Trust, Liverpool, United Kingdom
10.1136/thoraxjnl-2013-204457.322
10.1136/thoraxjnl-2013-204457.323
Introduction and Objectives NICE Guidance for bronchial thermoplasty (BT) recommended the collection of safety and efficacy
outcomes through the BTS Difficult Asthma Registry. This study
summarises the data collected to June 2013, with objectives of
describing the demographic and baseline characteristics of
patients undergoing BT and early consideration of safety and
efficacy, which will be updated for presentation at the December
2013 meeting.
Methods Records for 21 patients from 5 UK centres were
studied. Age, gender, lung function and quality of life were compared to those reported in two previous clinical trials. Potential
safety issues were examined and efficacy outcomes compared to
baseline.
Results Data:20 baseline records, 62 BT procedure records, 9
patients followed up to 6 months, 7 followed up to 12 months.
At follow-up, 12 patients had data at 6 and/or 12 months for
pre bronchodilator FEV1 and AQLQ to enable comparison with
baseline. Baseline demographics and characteristics are presented
in Table 1.
Outcomes: one patient was re-admitted to hospital for 3 days
with an exacerbation after the second of three routine BT procedures, but recovered to complete the final procedure. 17 patients
were admitted post-procedure (max 8 days) but no adverse outcomes were reported. Mean AQLQ score at 6 months was
4.61 ± 1.80 (n = 10). 6/10 patients had improved AQLQ (>
0.5 above baseline) at 6 months and 2/3 at 12 months. 1/10
patients had worse AQLQ (> than 0.5 below baseline) at 6
months and 0/3 at 12 months. Mean pre-bronchodilator FEV1
(% of predicted) at 6 months was 64.88 ± 26.57 (n = 8) and at
12 months 75.20 ± 13.77 (n = 5).
Conclusions Early indications are that this cohort are marginally
older and have worse mean lung function and AQLQ scores at
baseline than patients in two previous clinical trials.No serious
issues relating to equipment or adverse outcomes were observed.
Patients were often admitted post-procedure - this may have
been precautionary, as there were no reports of unanticipated
procedural morbidity. To date, efficacy outcomes appear consistent with those observed in previous clinical trials, with a suggestion of smaller improvement in AQLQ score.
Background Non-invasive ventilation (NIV) is an established
treatment for patients with acute ventilatory failure. It can be
successfully provided on a specialist ward, rather than intensive
care (ICU) when certain criteria are met. It is frequently delivered outside ICU when a patient is deemed not suitable for invasive ventilation.
Methods Deaths in 2012 on our dedicated ventilation unit were
analysed as part of ongoing clinical governance. Information on
demographics, admission diagnosis, respiratory and metabolic
acidosis, consolidation or pulmonary oedema on chest radiograph reports, Glasgow Coma Score (GCS), serum creatinine
and hospital length of stay prior to NIV were recorded. Escalation of care and resuscitation decisions were noted.
Results There were 228 admissions for acute NIV, with 31
recorded deaths (13.6%), 22 case notes were available for
review. Mean age was 79 years, 77.3% had known COPD,
admission median MRC score of 4, and 18.2% had been in hospital for >7 days before NIV. All had acute hypercapnic respiratory failure. Not for resuscitation decisions had been made for
95.5% prior to NIV, and 100% had NIV as a ‘ceiling of care’.
Mean pH was 7.25 (SD 0.06), similar to previous reports of
admissions to our unit1, 22% had mixed acidosis (BE <-2.0
mmol/l). GCS was <8 in 9% and 36.4% had serum creatinine
>100 mmol/l, all triggering alerts for acute kidney injury. Admission diagnoses are shown in figure 1. Radiographic consolidation
was reported in 59.1% and pulmonary oedema in 18.2%.
Abstract P171 Table 1. Baseline demographics and characteristics.
BT registry
AIR2 trial
AIR trial
44.3 ± 11.5 (n=21)
40.7 ± 11.9 (BT)
40.0 ± 11.2 (BT)
Range 23-69
40.6 ± 11.9 (C)
40.8 ± 12.1 (C)
% female
57
59
57
72.5 ± 10.9 (BT)
Mean age (years)
Pre-bronchodilator FEV1
70.25 ± 23.5 (n=16)
77.8 ± 15.7 (BT)
(% of predicted)
range: 22-105
79.7 ± 15.1 (C)
74.9 ± 8.9 (C)
AQLQ score
4.17 ± 1.2 (n=14)
4.30 ± 1.17 (BT)
5.6 ± 0.9 (BT)
range 2.44 - 6.31
4.32 ± 1.21 (C)
5.6 ± 0.9 (C)
Monitoring and management of sleep
disordered breathing and respiratory
failure
P172
ACUTE NIV AND MORTALITY - FAILURE OF DELIVERY OR
PATIENT SELECTION?
Thorax 2013;68(Suppl 3):A1–A220
Abstract P172 Figure 1. Admitting diagnoses based on initial
clinician assessment.
Conclusion The mortality of patients receiving acute NIV is
low2. Most deaths had an underlying diagnosis of COPD, they
were an elderly frail group, deemed inappropriate for escalation
to critical care. There were multiple risk factors for NIV failure
on initiation of therapy. Whilst a trial of NIV may have been
appropriate based purely on blood gases, it was at high risk of
failure and discussion about end of life care may have offered an
alternative approach.
REFERENCES
1. Chakrabarti et al. Thorax 2009;857–62.
2. Roberts et al. Thorax 2010;43–8.
A153
Thorax: first published as 10.1136/thoraxjnl-2013-204457.323 on 14 November 2013. Downloaded from http://thorax.bmj.com/ on May 30, 2020 by guest. Protected by copyright.
(BTS) Difficult Asthma Network)., London, UK; 4Queen's University Belfast (on behalf of
the British Thoracic Society (BTS) Difficult Asthma Network)., Belfast, UK
Keep reading this paper — and 50 million others — with a free Academia account
Objetiva-se investigar como o patriarcado influencia o acesso à justiça, explorando o contrato social, o Mito de Medusa e conceitos filosóficos antigos. A fundamentação teórica examina as estruturas patriarcais presentes no contrato social, as narrativas culturais que marginalizam as mulheres e as contribuições da filosofia antiga para reflexão das questões de gênero. A metodologia adotada é qualitativa, analisando interações culturais e jurídicas por meio de uma abordagem dedutiva. Os resultados revelam a complexidade das relações de poder e as barreiras que as mulheres enfrentam no sistema jurídico. Destaca-se a necessidade de desconstruir as normas patriarcais para promover uma justiça mais inclusiva e igualitária. A justificativa para este estudo reside na urgência de superar as desigualdades de gênero e criar um ambiente onde todos tenham acesso equitativo à justiça. Reconhecendo a importância de enfrentar as raízes profundas do patriarcado, este artigo busca contribuir para um debate acadêmico e social que promova mudanças positivas em direção a uma sociedade mais justa e igualitária para todos.
The land use land cover change and its modeling approach has recently been considered by the scientific community to observe environmental changes. Remote Sensing and Geographical Information System (GIS) give major techniques which can be useful in the analysis at the town locale as well as the city levels. RS data from Thematic Mapper sensor of 1998, 2002, 2010, 2014, and 2018, Operational Land Imager of 2018 were used for the analysis. The study used a supervised classification technique for classification, and Cellular Automata Markovian (CA-Markov) Model analysis was used for future projection of 2038. The result shows that the projected the year 2038 with 0.9079 K-standard value of stimulation, the study further uses Maximum likelihood classifier (MLC) a supervised classification method to classify the images. The study reveals a continuous pattern of urban growth from 3.96 km2 in 2018 to 4.73 in 2038 in terms of settlement growth, dense vegetation has decreased from 11.73 in ...
Lynch syndrome is an autosomal dominant disorder caused by germline mutations in DNA mismatch repair (MMR) system genes, such as MLH1, MSH2, MSH6, or PMS2. It is the most common hereditary colorectal cancer syndrome. Screening is regularly performed by using microsatellite instability (MSI) or immunohistochemistry for the MMR proteins in tumor samples. However, in a proportion of cases, MSI is found or MMR immunohistochemistry is impaired in the absence of a germline mutation in MMR genes, BRAF mutation, or MLH1 hypermethylation. These cases are defined as Lynch-like syndrome. Patients with Lynch-like syndrome represent a mixture of truly hereditary and sporadic cases, with a risk of colorectal cancer in first-degree relatives that is between the risk of Lynch syndrome in families and relatives of sporadic colon cancer cases. Although multiple approaches have been suggested to distinguish between hereditary and sporadic cases, a homogeneous testing protocol and consensus on the adeq...